This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor.—
Some authors link psoriasis with the presence of autoantibodies and the absence of T suppressor cells.1 Plasmapheresis by way of elution of such autoantibodies may serve as a possible mode of therapy in psoriasis. Subsequent to the observation of Dau2 of the clearing of psoriasis after plasmapheresis, as well as our own observations of the clinical and immunologic effects of peritoneal dialysis on psoriasis,3,4 we decided to perform plasmapheresis and to evaluate its effect on the immunologic system in a patient with psoriasis. The result of this treatment was a complete lack of response of the psoriatic lesions, with no notable influence on the immunologic system.
Report of a Case.—
An 18-year-old man had been suffering from generalized, plaque-type psoriasis since the age of 17 years and had been treated only with fluoridated corticosteroid ointments (0.025% fluocinolone acetonide) under occlusive dressings. This mode of
Halevy S, Ideses C, Shohat B, Feuerman EJ. Plasmapheresis for Psoriasis. Arch Dermatol. 1982;118(5):292. doi:10.1001/archderm.1982.01650170006008
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.